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Editors of journals are the gatekeepers and arbiters of the scientifi c record. They grant 
legitimacy to research, which, in turn, shapes public policy, infl uences the direction of future 
research and informs professional choices, from medical treatments to business strategies. 
Publication in academic journals can result in fi nancial rewards and personal accolades for 
authors. It is crucial for professional advancement within academia, offering a quantifi able, 
widely accepted and easily interpreted indication of scholarly accomplishment.2 Given the 
signifi cant powers that accompany their position, journal editors must put themselves at the 
front lines of defence against academic misconduct, including undue infl uence, fraud, 
fabrication and plagiarism in research. There is no doubt that the majority of editors take 
these responsibilities very seriously. Nevertheless, it bears examining how editors can ensure 
that they are working to the highest ethical standards, neither abusing their positions for 
personal or professional gain nor shirking from their duties of holding authors, peer reviewers 
and publishers to high standards of integrity in research.
Promoting honesty in authorship and infl uence
As David Robinson in Chapter 3.18 in this volume and Melissa Anderson and Takehito Kamata 
in Chapter 3.19 in this volume discuss, unjustifi ed authorship (honorary or ghost authorship) 
bestows false credit to individuals who played no signifi cant role in the research being 
reported. Likewise, failure to identify signifi cant contributors as authors denies readers the 
opportunity to consider the potential infl uence or agenda of those contributors.3 Because 
authorship establishes lines of accountability to all stages of research, editors should require 
authors and those who receive public acknowledged to identify their specifi c contribution to 
the work.4 Dishonest authorship is not uncommon; for instance, a survey of articles published 
in six medical journals in 2008 found that one-fi fth (21 per cent) included an undeserving 
honorary author, and 8 per cent of articles may have omitted important contributors.5 Some 
biomedical journals, whose failure to uphold integrity in research arguably poses some of 
the greatest societal risk, have adopted one promising model: participating journals require 
authors to submit a ‘contributor list’ that details each author’s roles throughout the course 
of the study, using categories such as ‘obtaining funding’, ‘coordinating, collecting, and 
analysing the data’ or ‘writing and revising the manuscript’.6
217 JOURNALS:  THE FRONTLINE OF INTEGRITY 
Confl ict-of-interest disclosure by authors is another important tool that editors use to 
increase transparency. Such disclosure policies seem to be increasing, particularly among 
medical journals. In the mid-1990s over one-third (34 per cent) of medical journals with 
circulations greater than 1,000 had disclosure policies, with that rate somewhat higher 
(46 per cent) for US medical journals.7 By 2010, 84 per cent of 180 medical journals published 
in the United Kingdom, United States or Canada had disclosure policies in place.8 Despite the 
improvement, many of these disclosure policies leave something to be desired. For instance, 
in the study cited above, only 28 per cent of medical journals state explicitly the sorts of 
activities or relationships that constitute a confl ict of interest.9
In addition to developing specifi c confl ict-of-interest disclosure instructions, journal editors 
should also make sure that their policies apply to all those who contribute to the research. A 
2008 survey of 256 high-impact medical journals found that, while 89 per cent of them had 
confl ict-of-interest policies for authors, only 54 per cent required each author in a study to 
sign a confl ict-of-interest statement. The result, the researchers argue, is that it may only be 
the corresponding author who is required to comply with a journal’s confl ict-of-interest policy, 
meaning that some contributors may avoid disclosure.10
Encouragingly, groups such as the World Association of Medical Editors and the Committee 
on Publication Ethics (COPE) have published guidance on the need for confl ict-of-interest 
disclosures. Nevertheless, there remains great variety between journal policies, both in what 
they ask authors to disclose, and whether they publish disclosures online. By moving towards 
comprehensive and universal confl ict-of-interest policies, editors can remove ambiguity for 
authors and help promote a higher standard of integrity across publications. To help improve 
journal policies, the International Committee of Medical Journal Editors, for example, has 
published a standard disclosure form that several member journals have already adopted.11
Planning responses to fabrication, fraud and plagiarism
Plagiarism, the fabrication of data, and the falsifi cation of research fi ndings can all constitute 
forms of corruption in academic research. Plagiarism becomes corruption when an author 
abuses a position of authority to gain from the ideas of another researcher, be it cribbing 
words and concepts or using another researcher’s data as his or her own. In the case of 
publicly funded research in particular, falsifi cation and fabrication abuse public trust and 
waste scarce resources on fi ndings that may turn back scientifi c progress or lead to 
misinformed public policy. Text recycling, or self-plagiarism, in which a contributor submits 
work that has been published in part or in full elsewhere, is also a practice against which 
editors must be vigilant. Duplication of work without appropriate attribution to the fi rst instance 
of publication is not just an ethical issue; it also distorts the academic record, fi lling it with 
redundant content, and it can represent a breach of copyright.12
With advances in technology, journal editors have a greater chance than ever to detect 
misconduct in research. With the development of text-matching software that checks 
submissions against an extensive database of published literature and other online sources, 
the number of retracted articles is increasing. In the United States, about 40 articles were 
retracted from biomedical journals annually in the late 1990s. By 2009 this had risen to over 
200, and by 2011 the number had doubled.13 In addition, new software has now advanced 
to the point that it allows identifi cation of the digital alteration of photographic data or 
discrepancies in data that might be indicative of fraud.14
Software can help identify some forms of misconduct; however, it is up to journal editors 
to make diffi cult judgement calls as to the seriousness of various forms of plagiarism, 
fabrication and fraud in articles that have been published or submitted for publication. The 
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UK-based Committee on Publication Ethics, with over 7,000 members globally, helps editors 
navigate these challenging decisions. The organisation offers editors guidelines and decision 
fl owcharts, while recognising that all cases are different. How an editor responds to plagiarism, 
for instance, may require considering whether misconduct was intentional: citing a few 
lines from another author’s work may be unintentional and the product of sloppy research, 
while claiming someone else’s data as one’s own is not a careless mistake.15 Even minor 
and unintentional infractions can lead to serious consequences, though. How editors react, 
and whether they alert the author’s institution, will also, in many cases, depend on the 
suspected intentions and research experience of the author. Editors may choose to send an 
‘educational letter to very junior researchers’ while taking more stringent steps with more 
senior authors.16
Given the great professional consequences that accompany allegations of research 
misconduct – regardless of their grounds or merit – journal editors have a responsibility fi rst 
to reach out to the author or authors suspected of wrongdoing. Nonetheless, for situations in 
which suspicions persist after responses from authors, journals should have systems in place 
to work closely with the institutions that employ the researcher or researchers.17 COPE calls 
for open lines of communication between institutions and the journals to address suspected 
research misconduct. Editors should be prepared to share with institutions or funders of 
research information they have that points to possible misconduct. To protect the research 
record, journals should likewise be prepared to issue expressions of concern in their 
publications while investigations are under way, and to publish retractions or corrections if 
investigations prove them to be necessary.18
Although many editors recognise and act upon their responsibility to maintain the integrity 
of the scientifi c record, others have proved to be reluctant to act when confronted 
with allegations of plagiarism or fraud. In 2009, one group of researchers reported that of 
212 articles they identifi ed as containing text that was likely to be plagiarised,19 more than a 
half received no action from the journal editors who were alerted to the duplication.20
Inadequate responses to allegations of misconduct are disappointing given the high 
stakes of much academic research. In one well-known case, the Journal of the American 
Academy of Child and Adolescent Psychiatry (JAACAP) published a study in 2001 that 
gravely misrepresented the suitability of the drug paroxetine to address adolescent depr-
ession.21 Publication in JAACAP legitimised the use of the drug to such an extent that 
sales representatives were encouraged to use the paper in their sales pitches.22 Subsequent 
consumer lawsuits against the pharmaceutical company resulted in the release of docu-
ments demonstrating that commercially damaging fi ndings had been hidden and data 
falsifi ed. In fact, eight adolescents who had taken the drug as part of the study had 
either harmed themselves or reported suicidal thoughts, compared to one adolescent in the 
placebo group.23 A Food and Drug Administration examiner who looked closely at the data 
believed the article’s claims to be greatly exaggerated.24 Rather than demonstrating ‘remark-
able effi cacy’ for treating adolescent depression, the drug’s harmful effects were quite 
serious.25
Requests for retraction were made to the journal on the basis of concerns that included 
fabrication and falsifi cation, failure to disclose the fi nancial interests of authors, and allegations 
that the article had been ghost written. The editor of the journal refused to retract the piece, 
claiming that, in the eight years since the publication of the article, there had been found ‘no 
evidence for such errors nor any justifi cation for retraction according to current editorial 
standards and scientifi c publication guidelines’.26 This response in the face of such serious 
allegations is troubling, both because of the considerable reach of the article within the 
medical community, and because of the health risks posed by the drug.
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Supporting whistleblowers
Journal editors are often the fi rst to be notifi ed of alleged misconduct by whistleblowers. 
Individuals who seek to shed light on research misconduct often do not receive suffi cient 
protection and support within the academic community.27 An allegation of misconduct places 
a whistleblower at risk of retaliation from colleagues and scrutiny from institution administrators. 
If an allegation is not handled properly by editors and administrators, the whistleblower faces 
subtle or overt denial of professional opportunities and alienation from colleagues.28 Such 
risks increase for junior scholars who make an accusation against a senior academic. While 
ensuring the allegations of misconduct are investigated by the appropriate bodies or 
authorities, editors must meet their responsibility to protect the anonymity of whistleblowers, 
and particularly vulnerable junior members of the academic community.
Holding editors and reviewers to high standards of integrity
To hold the scientifi c community to high standards of integrity, editors must hold themselves 
and their peer reviewers to the same standards fi rst. The degree of power they hold over 
prospective contributors requires measures to ensure that their authority is not abused for 
private gain.
Competing interests of editors and peer reviewers compound the risk of bias in editorial 
decisions, and it is the responsibility of editors to ensure that confl icts between public and 
private benefi ts are disclosed and appropriately managed. The most patent corruption risk in 
academic publishing arises when the editor or peer reviewer stands to gain fi nancially from a 
decision to accept or reject a submitted manuscript. The benefi t can be direct, as in the 
instance when an editor or peer reviewer holds stock in a company whose product is 
evaluated in a paper submitted to the journal. The possibility of fi nancial gain can also take 
less direct forms, as when the editor has consulted for a company or research group in direct 
competition with the authors of a manuscript.29
Because of publication being the unique ‘coin of the realm’ in science,30 however, non-
fi nancial confl icts of interest also create powerful incentives for abuses of authority. In the 
scientifi c fi eld, where personal interest and the interest of science are always held in tension, 
these confl icts are harder to identify and manage than the more apparent ones that involve 
immediate fi nancial gain. At the same time, the behaviours motivated by non-fi nancial confl icts 
of interest have equally serious consequences. For example, an editor may cite an unjustifi ed 
number of sources from his or her own publication in editorials and deny recognition to 
others. A peer reviewer may likewise purposefully delay the review of a manuscript similar to 
his or her own work so as to secure priority in publication, or recommend the rejection 
of an article on non-scientifi c grounds because of a strong personal belief on a controversial 
issue.31
Although many journals have introduced confl ict-of-interest policies for authors in recent 
years, similar policies for editors and reviewers are less common. For example, fewer than a 
quarter of high-impact journals surveyed for one study across twelve disciplines had policies 
addressing confl icts of interest for editors.32 In another study of medical journals, fewer than 
a half had such policies for editors (40 per cent) or reviewers (46 per cent), while 12 per cent 
published editors’ disclosures of competing interests.33 In order to improve the transparency 
of the reviewing process, COPE recommends that journals adopt policies requiring those 
involved in the editorial process to declare confl icts of interest.34 A reviewer is then obliged 
to decline to review a manuscript if he or she has connections, whether competitive 
or cooperative, to the authors or institutions mentioned in the manuscript.35 When a journal 
establishes its policies and guidelines, it should clearly defi ne what is meant by ‘confl ict 
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of interest’ and how such confl icts 
will be managed, and make the 
documents available to the public.36
Because of the reward structure 
of science, editors also have an 
inevitable interest in increasing the 
prestige of their journals. Recent 
reports suggest that some attempt 
to boost their impact factor scores 
by resorting to a practice known as 
coercive or manipulative citation: 
requiring authors to add citations 
from a journal to their paper as a 
condition of publication.37 A recent 
survey of over 6,000 academics in 
the social sciences identifi ed 175 
journals as coercers, and found that 
coercion is more likely to affect 
junior than senior academics, who 
are less likely to challenge editorial directions.38 Editors who coerce citations to boost the 
standing of their journals abuse their authority and distort the true trail of progressing scholarly 
insight.
Journal editors play a central role in preventing corruption in the ways they defi ne, follow 
and enforce integrity policies for all those involved in the journal’s publication process. To 
respond to current corruption risks in academic publishing, editors should follow the 
recommendations established by the Committee on Publication Ethics for developing 
transparent policies and contingency plans, rather than being forced to do so by an 
unanticipated crisis that threatens the reputation of the journal and, in the long run, can erode 
public trust in the integrity of science.
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